Clinical trial
Safety and Efficacy Study of Lithium in Bipolar Disorder
NCT00422331 · JDS Pharmaceuticals, Industry · Unknown status
Key facts
| NCT number | NCT00422331 |
|---|---|
| Title | Safety and Efficacy Study of Lithium in Bipolar Disorder |
| Official title | Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Lithium in Bipolar I Disorder |
| Lead sponsor | JDS Pharmaceuticals, Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorder, Mania |
| Intervention type | Drug |
| Interventions | Lithium Carbonate Capsule |
| Enrollment | 206 |
| Start date | Jan 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jan 15, 2007 |
| Last update posted | Aug 14, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: